leadf
logo-loader
CSE:XPHY OTCQB:XPHYF

XPhyto Therapeutics Corp.

Receive alerts
Market:
CSE
Market Cap:
$97.67 m
Price
1.40 CAD
Change
6.87%
52 weeks high
3.45
52 weeks low
1.31

In brief

XPhyto was created to capture the next generation drug delivery, diagnostic, and phytotherapeutic investment opportunities: precision transdermal and oral dissolvable drug dosage forms; rapid, low-cost, point-of-care infectious disease screening tools, and standardized and clinically validated plant-based active pharmaceutical ingredients focused on European markets

Snapshot

The bioscience company and its exclusive diagnostic partner, 3a-Diagnostics GmbH, have developed a point-of-care lateral flow test to detect COVID-19 viral RNA in patient saliva